Trial Profile
A Randomized, Double-blinded, Phase 2a Study to Assess the Safety and Pharmacokinetics of a Sustained Release Formulation of Sodium Nitrite (TV1001sr) in Patients With Diabetic Neuropathic Pain (DNP)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Sep 2023
Price :
$35
*
At a glance
- Drugs Sodium nitrite (Primary)
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Adverse reactions
- Sponsors TheraVasc
- 21 Sep 2023 According to JanOne media release, data from this study presented at the Ohio Society of Interventional Pain Physicians Annual Meeting.
- 18 Aug 2023 According to JanOne media release, prior data from this study will be presentedted at the Ohio Society of Interventional Pain Physicians Annual Meeting.
- 02 Aug 2016 Status changed from active, no longer recruiting to completed, according to TheraVasc media release.